Schedule 13G ownership disclosure

AIMEI HEALTH TECHNOLOGY CO

Ordinary Shares, $0.0001 par value per share · CUSIP: G01341109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • WOLVERINE ASSET MANAGEMENT LLC

    Shares: 654,039 · Class: 7.25%

  • Wolverine Trading Partners, Inc.

    Shares: 654,039 · Class: 7.25%

  • Wolverine Holdings, L.P.

    Shares: 654,039 · Class: 7.25%

  • Christopher L. Gust

    Shares: 654,039 · Class: 7.25%

  • Robert R. Bellick

    Shares: 654,039 · Class: 7.25%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-002636
Form type
SCHEDULE 13G/A
Filer
Aimei Health Technology Co., Ltd.
CIK
CIK 1979005
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub